BriaCell Therapeutics Corp. (BCTX )

Currency in USD Disclaimer
$4.64 +$0.54 (13.17%)
Open 02/05/2025
$4.04
$4.84
$0.35
$7.87

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

  • Symbol BCTX
  • Company BriaCell Therapeutics Corp.
  • Price $4.64
  • Changes Percentage 13.17
  • Change 0.54
  • Day Low $4.04
  • Day High $4.84
  • Year High $7.87
  • Year Low $0.35
  • Market Cap $13,673,802
  • Price Avg 50 EMA (D) $1.02
  • Price Avg 200 EMA (D) $1.07
  • Exchange NASDAQ
  • Volume 535,092
  • Average Volume 1,568,276
  • Open $4.04
  • Previous Close $4.1
  • EPS -13.35
  • PE -0.35
  • Earnings Announcement 2025-03-17 20:00:00
  • Shares Outstanding $2,946,940

Company brief: BRIACELL THERAPEUTICS CORP. (BCTX )

BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.

BCTX Corporation News

BRIACELL THERAP (BCTX) Upgraded to Buy: What Does It Mean for the Stock?

BRIACELL THERAP (BCTX) Upgraded to Buy: What Does It Mean for the Stock?

February 5, 2025 at 6:00 pm ET

zacks.com -- BRIACELL THERAP (BCTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term....

Income Statement